Figure 2
Figure 2. Quantification of CD4+CCR5+ cells, CD4+CD45RO+ cells, and CD4+CD45RO+CCR5+ cells in neonatal tissue and cord blood. Data are derived from spectral imaging analyses of triple immunohistochemical stainings and flow cytometry. The graphs show mean percentages ± SEM of CD4+CCR5+ (A), CD4+CD45RO+ (B), and CD4+CD45RO+CCR5+ (C) cells. Percentages of CCR5+, CD45RO, and triple-positive CD4+ T cells in various tissues all differed significantly from those of CD4+ T cells in cord blood (P < .001 by Student t test). CD4+ T cells from gut epithelium and gut lymphoid aggregates (LA) expressed significantly more CCR5 and CD45RO than CD4+ T cells derived from lymph nodes (P < .01 and P = .05, respectively).

Quantification of CD4+CCR5+ cells, CD4+CD45RO+ cells, and CD4+CD45RO+CCR5+ cells in neonatal tissue and cord blood. Data are derived from spectral imaging analyses of triple immunohistochemical stainings and flow cytometry. The graphs show mean percentages ± SEM of CD4+CCR5+ (A), CD4+CD45RO+ (B), and CD4+CD45RO+CCR5+ (C) cells. Percentages of CCR5+, CD45RO, and triple-positive CD4+ T cells in various tissues all differed significantly from those of CD4+ T cells in cord blood (P < .001 by Student t test). CD4+ T cells from gut epithelium and gut lymphoid aggregates (LA) expressed significantly more CCR5 and CD45RO than CD4+ T cells derived from lymph nodes (P < .01 and P = .05, respectively).

Close Modal

or Create an Account

Close Modal
Close Modal